Have a personal or library account? Click to login
Maternal Respiratory Syncytial Virus (RSV) Vaccination: Current Status and Comparison to Monoclonal Antibodies (mAbs) for RSV Prevention in Infants and Children Cover

Maternal Respiratory Syncytial Virus (RSV) Vaccination: Current Status and Comparison to Monoclonal Antibodies (mAbs) for RSV Prevention in Infants and Children

Journal of Mother and Child
Volume 29 (2025): Issue 1 (February 2025)
By: Ahila AliORCID,  Laiba ShamimORCID,  Ahmed IbrahimORCID,  Muhammad Abdullah HumayunORCID,  Muhammad Hamza KhanORCID,  Anum AkbarORCID,  Sanmit JindalORCID,  Shahzaib AhmedORCID,  Jamuna ShresthaORCID and  Muhammad Abdullah NveedORCID  
Open Access
|Aug 2025

References

  1. Aliprantis AO, Shaw CA, Griffin P, Farinola N, Railkar RA, Cao X, et al. A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Hum. Vaccines Immunother. 2021;17(5):1248–1261.
    Search in Google ScholarBack to article
  2. Shaw CA, Ciarlet M, Cooper BW, Dionigi L, Keith P, O'Brien KB, et al. The path to an RSV vaccine. Curr. Opin. Virol. 2013;3(3):332–342.
    Search in Google ScholarBack to article
  3. Carroll KN, Wu P, Gebretsadik T, Griffin MRF, Dupont Wd, Mitchel EF, et al. The severity-dependent relationship of infant bronchiolitis on the risk and morbidity of early childhood asthma. J. Allergy Clin. Immunol. 2009;123(5):1055–1061, 1061.e1.
    Search in Google ScholarBack to article
  4. Lozano, R. Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128.
    Search in Google ScholarBack to article
  5. Shi, T, McAllister DA, O'Brien KL, Simoes EA, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet Lond. Engl. 2017;390(10098):946–958.
    Search in Google ScholarBack to article
  6. NIAID: National Institute of Allergy and Infectious Disease. Respiratory Syncytial Virus (RSV): https://www.niaid.nih.gov/diseases-conditions/respiratory-syncytial-virus-rsv.
    Search in Google ScholarBack to article
  7. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. 2000; Clin. Microbiol. Rev. 13(3):371–384.
    Search in Google ScholarBack to article
  8. Battles, MB, McLellan, JS. Respiratory syncytial virus entry and how to block it. Nat. Rev. Microbiol. 2019; 17(4):233–245.
    Search in Google ScholarBack to article
  9. Levine S, Klaiber-Franco R, Paradiso PR. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 1987;68 (Pt 9):2521–2524.
    Search in Google ScholarBack to article
  10. Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics. Cell. Mol. Life Sci. 2020;CMLS 77(24):5045–5058.
    Search in Google ScholarBack to article
  11. Ouyang Y, Liao H, Hu Y, Luo K, Hu S, Zhu H. Innate Immune Evasion by Human Respiratory Syncytial Virus. Front. Microbiol. 2022;13:865592.
    Search in Google ScholarBack to article
  12. Killikelly A, Tunis M, House A, Quach C, Vaudy W, Moore D. Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Can. Commun. Dis. Rep. Releve Mal. Transm. Au Can. 2020;46(4):56–61.
    Search in Google ScholarBack to article
  13. Díez-Domingo J, Sáez-Llorens X, Rodriguez-Weber MA, Epalza C, Chatterjee A, Chiu CH, et al. Safety and immunogenicity of a ChAd155-vectored respiratory syncytial virus (RSV) vaccine in healthy RSV-seropositive children 12–23 months of age. J. Infect. Dis. 2023;227(11):1293–1302.
    Search in Google ScholarBack to article
  14. Cunningham CK, Karron R, Muresan P, McFarland EJ, Perlowski C, Libous J, et al. Live-attenuated respiratory syncytial virus vaccine with deletion of RNA synthesis regulatory protein M2-2 and cold passage mutations is overattenuated. Open Forum Infect. Dis. 2019;6(6)A:ofz212.
    Search in Google ScholarBack to article
  15. Belshe RB, Van Voris, LP, Mufson MA. Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. J. Infect. Dis. 1982;145(3):311–319.
    Search in Google ScholarBack to article
  16. Groothuis JR, King SJ, Hogerman DA, Paradiso PR, Simoes EA. Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia. J. Infect. Dis. 19998;177(2): 467–469.
    Search in Google ScholarBack to article
  17. Tristram DA, Welliver RC, Mohar CK, Hogerman DA, Hildreth SW, Paradiso P. Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18–36 months old. J. Infect. Dis. 1993;167(1):191–195.
    Search in Google ScholarBack to article
  18. Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, K Jensen, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 1969;89(4):422–434.
    Search in Google ScholarBack to article
  19. Graham BS. Vaccine development for respiratory syncytial virus. Curr. Opin. Virol. 2017;23:107–112.
    Search in Google ScholarBack to article
  20. Tang RS, Spaete RR, Thompson MW, MacPhail M, Guzzetta JM, Ryan PC, et al. Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults. Vaccine. 2008;26(50):6373–6382.
    Search in Google ScholarBack to article
  21. Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, et al. The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines. Vaccine. 2007; 25(42):7372–7378.
    Search in Google ScholarBack to article
  22. Cunningham CK, Karron RA, Muresan P, Kelly MS, McFarland EJ, Perlowski C. Evaluation of recombinant live-attenuated respiratory syncytial virus (RSV) vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV-seronegative children. J. Infect. Dis. 2022;226(12):2069–2078.
    Search in Google ScholarBack to article
  23. McFarland EJ, Karron RA, Muresan P, Cunningham CK, Valentgine ME, Perlowski C, et al. Live-attenuated respiratory syncytial virus vaccine candidate with deletion of RNA synthesis regulatory protein M2-2 is highly immunogenic in children. J. Infect. Dis. 2018;217(9):13470–1355.
    Search in Google ScholarBack to article
  24. McFarland, EJ, Karron RA, Muresan P, Cunningham CK, Perlowski C, Libous J, et al. Live-Attenuated respiratory syncytial virus vaccine with M2-2 deletion and with small hydrophobic noncoding region is highly immunogenic in children. J. Infect. Dis. 2020;221(12):2050–2059.
    Search in Google ScholarBack to article
  25. Malkin E, Yogev R, Abughali N, Sliman J, Wang CK, Zuo F, et al. Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age. PloS One. 2013; 8(10):e77104.
    Search in Google ScholarBack to article
  26. American Academy of Pediatrics Committee on Infectious Diseases & American Academy of Pediatrics Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:e620–638.
    Search in Google ScholarBack to article
  27. CDC Health Alert Network (HAN). Limited Availability of Nirsevimab in the United States—Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023–2024 Respiratory Virus Season: https://www.cdc.gov/han/2023/han00499.html (2024).
    Search in Google ScholarBack to article
  28. Sun, M, Lai H, Na F, Li S, Qiu X, Tian J, et al. Monoclonal antibody for the prevention of respiratory syncytial virus in infants and children: A systematic review and network meta-analysis. JAMA Netw. Open. 2023;6(2):e230023.
    Search in Google ScholarBack to article
  29. Fernández P, Trenholme A, Abarca K, Griffin MP, Hultquist M, Harris B, et al. A phase 2, randomized, double-blind safety and pharmacokinetic assessment of respiratory syncytial virus (RSV) prophylaxis with motavizumab and palivizumab administered in the same season. BMC Pediatr. 2010;10:38.
    Search in Google ScholarBack to article
  30. Munoz FM, Englund JA. Respiratory syncytial virus. Matern. Immun. 2019;213–234. doi: 10.1016/B978-0-12-814582-1.00011-5.
    Open DOISearch in Google ScholarBack to article
  31. Chu HY, Tielsch J, Katz J, Margaret AS, Khatry S, LeClerq SC, et al. Transplacental transfer of maternal respiratory syncytial virus (RSV) antibody and protection against RSV disease in infants in rural Nepal. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 2017;95:90–95.
    Search in Google ScholarBack to article
  32. Glezen WP, Paredes A, Allison, JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J. Pediatr. 1981;98(5):708–715.
    Search in Google ScholarBack to article
  33. Aranda SS, Polack FP. Prevention of pediatric respiratory syncytial virus lower respiratory tract illness: Perspectives for the next decade. Front. Immunol. 2019;10:1006.
    Search in Google ScholarBack to article
  34. The American College of Obstetricians and Gynecologists. Should I get the RSV vaccine during pregnancy?: https://www.acog.org/womens-health/experts-and-stories/ask-acog/should-i-get-the-rsv-vaccine-during-pregnancy.
    Search in Google ScholarBack to article
  35. American Medical Association. CDC guidelines for maternal RSV vaccine and latest FDA approvals with Sandra Fryhofer, MD: https://www.ama-assn.org/delivering-care/public-health/cdc-guidelines-maternal-rsv-vaccine-and-latest-fda-approvals-sandra.
    Search in Google ScholarBack to article
  36. Simões EAF, Center KJ, Tita ATN, Swanson, KA, Radley D, Houghton J, et al. Prefusion F protein-based respiratory syncytial virus immunization in pregnancy. N Engl J Med. 2022;386:1615–1626.
    Search in Google ScholarBack to article
  37. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin. Dev. Immunol. 2012;2012:985646.
    Search in Google ScholarBack to article
  38. Centers for Disease Control and Prevention. RSV vaccine guidance for pregnant people: https://www.cdc.gov/rsv/hcp/vaccine-clinical-guidance/pregnant-people.html.
    Search in Google ScholarBack to article
  39. Madhi SA, Polack FP, Piedra PA, Munoz FM, Trenholme AA, Simões EAF, et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants. N. Engl. J. Med. 2020;383(5):426–439.
    Search in Google ScholarBack to article
  40. Bebia Z, Reyes O, Jeanfreau R, Kantele A, Graciela De Leon R, Sánchez MG, et al. Safety and immunogenicity of an investigational respiratory syncytial virus vaccine (RSVPreF3) in mothers and their infants: A phase 2 randomized trial. J. Infect. Dis. 2023;228(3):299–310.
    Search in Google ScholarBack to article
  41. Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants. N. Engl. J. Med. 2023;388(16): 1451–1464.
    Search in Google ScholarBack to article
  42. Centers for Disease Control and Prevention. RSV (Respiratory Syncytial Virus) Immunizations: https://www.cdc.gov/vaccines/vpd/rsv/index.html (2024).
    Search in Google ScholarBack to article
  43. Centers for Disease Control and Prevention. Vaccines for Children (VFC) Program: https://www.cdc.gov/vitalsigns/vaccines-for-children/index.html.
    Search in Google ScholarBack to article
  44. Wodi AP. Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger — United States, 2024. MMWR Morb. Mortal. Wkly. Rep. 2024;73.
    Search in Google ScholarBack to article
  45. Centers for Disease Control and Prevention. About the Vaccines for Children (VFC) Program: https://www.cdc.gov/vaccines-for-children/about/index.html.
    Search in Google ScholarBack to article
  46. Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: A multicenter questionnaire study. Pediatr. Infect. Dis. J. 2019;38(9):944–951.
    Search in Google ScholarBack to article
  47. Kherfan T, Sallam M. Prospective attitudes towards respiratory syncytial virus (RSV) vaccination: Validation of a survey instrument among young females in Jordan pending vaccine authorization. Vaccines. 2023;11(8):1386.
    Search in Google ScholarBack to article
  48. Limaye RJ, Sauer M, Njogu R, Singh P, Fesshaye B, Karron RA. Characterizing attitudes toward maternal RSV vaccines among pregnant and lactating persons in Kenya: Key considerations for demand generation efforts for vaccine acceptance. J. Pediatr. Infect. Dis. Soc. 2023;12(12):638–641.
    Search in Google ScholarBack to article
DOI: https://doi.org/10.34763/jmotherandchild.20252901.d-25-00012 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Journal RSS Feed
Language: English
Page range: 93 - 100
Submitted on: Apr 15, 2025
Accepted on: May 28, 2025
Published on: Aug 16, 2025
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Respiratory syncytial virus,
vaccine,
monoclonal antibodies,
immunization,
pregnancy
Related subjects:
Medicine,
Clinical medicine,
Pediatrics and juvenile medicine,
Paediatric haematology and oncology,
Public health

© 2025 Ahila Ali, Laiba Shamim, Ahmed Ibrahim, Muhammad Abdullah Humayun, Muhammad Hamza Khan, Anum Akbar, Sanmit Jindal, Shahzaib Ahmed, Jamuna Shrestha, Muhammad Abdullah Nveed, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 29 (2025): Issue 1 (February 2025)Next article